Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06174727 · ClinicalTrials.gov registry record
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
A clinical trial of Intracranial Aneurysm, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 11
- Study locations
NCT06174727: Recruiting study of Intracranial Aneurysm, sponsored by Montefiore Medical Center.
NCT06174727 is a study of Intracranial Aneurysm that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 5,000 participants, below the 8,839-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (43% lower). The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06174727, a study of Intracranial Aneurysm, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.
Primary Outcome
Technical Success will be determined by successful deployment of the flow diverter stent or endosaccular flow disruptors. A dichotomous determination (i.e., Yes/No) will be made and summarized for this study.
Conditions Studied
Study Locations (11)
Florida
- University of Miami - Coral Gables
- Mayo Clinic Florida - Jacksonville
- Sarasota Memorial Research Institute - Sarasota
New York
- University at Buffalo - Buffalo
- Montefiore Medical Center Department of Neurosurgery - The Bronx
Massachusetts
- Lahey Hospital and Medical Center - Burlington
Michigan
- Munson Medical Center - Traverse City
New Jersey
- Robert Wood Johnson University - New Brunswick
Pennsylvania
- Geisinger Health - Danville
Texas
- HCA Houston Healthcare Kingwood - Kingwood
Ontario
- Toronto Western Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2026-06 |
What NCT06174727 shows while recruiting
NCT06174727 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, below the 8,839-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 0 interventions.
NCT06174727 lists 11 locations in 8 states (Florida, New York, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06174727 about?
NCT06174727 is a clinical study titled "International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)". This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.
What is the current status of trial NCT06174727?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-10-01. Estimated completion is 2026-06.
What conditions does trial NCT06174727 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
Who is sponsoring clinical trial NCT06174727?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06174727 being conducted?
This trial has 11 study locations across Florida, Massachusetts, Michigan, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06174727's enrollment target sits among peer trials
5,000 3rd of 14 higher than 12 of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI